:: Volume 24, Issue 5 (Sep and Oct 2022) ::
Koomesh 2022, 24(5): 614-619 Back to browse issues page
Effect of intranasal midazolam with/without inhalation sedation (N2O/O2) in 3‒6-year-old uncooperative dental patients
Nahid Askarizadeh , Fereshteh Dehghan , Yasaman Rezvani , Leila Eftekhar , Seyed Mohammad Mireskandari , Mona Naghibi
Abstract:   (625 Views)
Introduction: Due to incomplete development of coping skills in children, they usually cannot cope with stressful situations like dental appointments. The present study aims to evaluate the effect of intranasal midazolam with/without inhalation sedation (N2O/O2) in children with high levels of dental anxiety.
Materials and Methods: This crossover double-blinded clinical trial was conducted on 14 uncooperative children aged 3‒6, who required at least two similar dental treatment visits. Children were randomly sedated by the combination of intranasal midazolam (0.5 mg/kg) and nasal drops of lidocaine hydrochloride (2%) with or without inhalation sedation (N2O/O2) during each visit. Houpt’s scale for sedation was used to evaluate the patient`s behavior and efficacy of the sedation by an independent pediatric dentist.
Results: The combination of midazolam and inhalation sedation was significantly more effective in overall behavior after 15 minutes and at the end of the treatment (P<0.05), but not at the time of onset and discharge (P>0.05).
Conclusion: To manage the behavior of the children with high levels of dental anxiety, the combination of inhalation sedation with intranasal midazolam can be efficiently used.
Keywords: Anxiety, Conscious Sedation, Intranasal Drug administration, Nitrous Oxide, Midazolam
Full-Text [PDF 874 kb]   (478 Downloads)    
Type of Study: Research | Subject: General
Received: 2021/06/18 | Accepted: 2022/03/15 | Published: 2022/09/27

Clinical trials code: IRCT2016111930971N1


XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 5 (Sep and Oct 2022) Back to browse issues page